Pacific Biosciences Of California reported $-65463000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US USD 570M 67M
Bruker BRKR:US USD 153.9M 44.8M
Danaher DHR:US USD 2.86B 306M
Fluidigm FLDM:US USD -25325000 9.16M
Illumina ILMN:US USD 349M 225M
Myriad Genetics MYGN:US USD -31900000 27.1M
Perkinelmer PKI:US USD 205.36M 198.73M
Roche Holding ROG:VX 13.44B 2.56B
Thermo Fisher Scientific TMO:US USD 2.6B 258M
Waters WAT:US USD 224.22M 10.15M